查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529628

美国抑钙素、IL-6、IL-10 测试市场规模、份额、趋势分析报告：按患者类型、类型、最终用途、应用、付款人类型、州、细分市场、预测，2024 年~2030年

U.S. Procalcitonin, IL-6, And IL-10 Tests Market Size, Share & Trends Analysis Report By Patient Type (Inpatient, Outpatient), By Type (Procalcitonin, IL-6, IL-10), By End Use, By Application, By Payer Type, By State, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10个工作天内

价格

美国抑钙素、IL-6、IL-10检测市场细分

根据Grand View Research最新报告显示，到2030年，美国抑钙素、IL-6、IL-10检测市场规模预计将达到3.005亿美元，复合年增长率预计将扩大至4.37%。美国败血症和细菌感染病例的增加是这些生物标记测试需求的关键驱动因素。这些测试对于感染疾病的早期发现和管理至关重要，从而推动市场成长。此外，测试技术的创新和改进，例如自动化和高通量系统，使这些测试变得更加容易和可靠，从而导致其使用量的增加。

PCT 检测已成为一种有价值的工具，因为 PCT 值升高与细菌感染有关，而 PCT 值降低则表明发炎是病毒性或非感染性原因。透过测量 PCT 值，临床医生可以区分细菌和病毒感染，指导抗生素治疗决策，并在不需要抗生素时降低抗生素处方率。以 PCT 为基础的抗生素治疗可减少抗生素暴露、缩短治疗时间并减少抗生素相关不利事件的发生率，所有这些都有助于实现抗菌药物管理的目标。

此外，IL-6 和 IL-10 检测透过提供有关全身性发炎和免疫异常严重程度的额外资讯来补充 PCT，这是抗菌药物管理决策中的重要考虑因素。 IL-6 水平升高与严重感染疾病和不良临床结果相关，IL-10 水平可能反映免疫抑制和继发感染易感性增加。基于生物标记的诊断测试，包括 IL-6 和 IL-10 检测，允许临床医生对患者进行风险分层、监测疾病进展，并根据患者个别特征和临床状态指导抗生素治疗。

COVID-19 大流行对美国抑钙素、IL-6 和 IL-10 检测市场产生了重大影响。大流行导致对生物标誌物测试的需求增加。这些生物标记对于评估患者 COVID-19 的严重程度和预后至关重要，从而推动了对这些测试的需求。医疗机构和专业人员已优先考虑 COVID-19 的管理和诊断，暂时将重点和资源转移到与 COVID-19 相关的诊断。这导致了检测的产量和利用率的增加，以帮助有效地控制这种疾病。对有效的 COVID-19 管理策略的迫切需求导致政府和私营部门对诊断测试（包括抑钙素、IL-6 和 IL-10）的研发进行了大量投资。这种财政支持加速了测试开发和可用性的进展。

成本限制是 PCT、IL-6 和 IL-10 测试在美国广泛使用的主要障碍。与生物标记测试相关的成本，包括测试获取、设备和人员培训，为医疗保健提供者和机构带来了财务挑战，特别是在资源有限的环境和未投保的患者群体中。报销政策和覆盖范围限制可能会加剧成本问题，限制生物标记检测的机会，并阻碍生物标记检测在临床实践中的采用。

美国抑钙素、IL-6、IL-10检测市场报告亮点

  • 住院型细分市场将在 2023 年占据最大的市场占有率，预计在预测期内复合年增长率将达到 4.5%。
  • 按类型划分，市场分为抑钙素、IL-6 和 IL-10。 IL-6细分市场在2023年占据最大收益占有率，为59.34%。
  • 按最终用途划分，医院在 2023 年占据最大的收益占有率。
  • 依付款人类型，市场分为保险和自付。 2023年，保险领域占据最大的市场占有率。
  • IL-6应用领域在2023年占据最大的收益占有率。脓毒症是 IL-6 的主要应用领域。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影响分析
    • 监管场景

第 4 章美国抑钙素、IL-6、IL-10 检测市场：按患者类型进行的业务分析

  • 细分仪表板
  • 美国抑钙素、IL-6、IL-10检测市场波动分析
  • 2018-2030 年美国抑钙素、IL-6、IL-10 检测市场规模与趋势分析（依患者类型）
  • 住院病人
  • 门诊

第五章美国抑钙素、IL-6、IL-10测试市场：按类型分类的业务分析

  • 细分仪表板
  • 美国抑钙素、IL-6、IL-10检测市场波动分析
  • 2018-2030年美国抑钙素、IL-6、IL-10检测市场规模及趋势分析（依类型）
  • 抑钙素
  • IL-6
  • IL-10

第六章美国抑钙素、IL-6、IL-10 测试市场：依应用进行业务分析

  • 细分仪表板
  • 美国抑钙素、IL-6、IL-10检测市场波动分析
  • 2018-2030 年美国抑钙素、IL-6、IL-10 检测市场规模及趋势分析（依应用）
  • 抑钙素
  • IL-6
  • IL-10

第7章美国抑钙素、IL-6、IL-10测试市场：依最终用途进行的业务分析

  • 细分仪表板
  • 美国抑钙素、IL-6、IL-10检测市场波动分析
  • 美国抑钙素、IL-6、IL-10 测试市场规模和趋势分析（按最终用途），2018-2030 年
  • 医院
  • 研究所
  • 其他的

第8章美国抑钙素、IL-6、IL-10测试市场：按付款人类型进行的业务分析

  • 细分仪表板
  • 美国抑钙素、IL-6、IL-10检测市场波动分析
  • 美国抑钙素、IL-6、IL-10 测试市场规模和趋势分析（按付款人类型），2018-2030 年
  • 保险
  • 自费

第9章美国抑钙素、IL-6、IL-10检测市场：各州业务分析

  • 2023 年和 2030 年美国抑钙素、IL-6、IL-10 检测市场占有率（按州）
  • 阿拉巴马州
  • 阿拉斯加州
  • 亚利桑那
  • 阿肯色州
  • 加州
  • 科罗拉多
  • 康乃狄克州
  • 德拉瓦
  • 佛罗里达
  • 乔治亚
  • 夏威夷
  • 爱达荷州
  • 伊利诺州
  • 印第安纳州
  • 爱荷华州
  • 堪萨斯州
  • 肯塔基州
  • 路易斯安那州
  • 主要的
  • 马里兰州
  • 麻萨诸塞州
  • 密西根州
  • 明尼苏达州
  • 密西西比州
  • 密苏里州
  • 蒙大拿
  • 内布拉斯加州
  • 内华达州
  • 新罕布夏州
  • 纽泽西州
  • 新墨西哥州
  • 纽约
  • 北卡罗来纳州
  • 北达科他州
  • 俄亥俄州
  • 奥克拉荷马
  • 奥勒冈
  • 宾州
  • 罗德岛
  • 南卡罗来纳州
  • 南达科他州
  • 田纳西州
  • 德克萨斯
  • 犹他州
  • 佛蒙特
  • 维吉尼亚
  • 华盛顿
  • 西维吉尼亚
  • 威斯康辛州
  • 怀俄明州

第10章竞争格局

  • 参与企业
  • 策略规划
  • 2023 年企业市场分析
  • 参与企业概况
    • ARUP Laboratories
    • Promega Corporation
    • Quest Diagnostics Incorporated
    • BIOMERIEUX
    • F. Hoffmann-La Roche Ltd.
    • Beckman Coulter, Inc.
    • Thermo Fisher Scientific, Inc.
    • QuidelOrtho Corporation
Product Code: GVR-4-68040-327-0

U.S. Procalcitonin, IL-6, And IL-10 Tests Market Segmentation

The U.S. procalcitonin, IL-6, and IL-10 tests market size is anticipated to reach USD 300.5 million by 2030 and is anticipated to expand at a CAGR of 4.37% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing cases of sepsis and bacterial infections in the U.S. are significant drivers of the demand for these biomarker tests. These tests are crucial for the early detection and management of infections, thereby driving the market growth. Furthermore, innovations and improvements in testing technologies, including automation and high-throughput systems, have made these tests more accessible and reliable, leading to an increase in their usage.

PCT testing has emerged as a valuable tool, as elevated PCT levels are associated with bacterial infections, while low PCT levels indicate viral or noninfectious causes of inflammation. By measuring PCT levels, clinicians can differentiate between bacterial & viral infections, guiding antibiotic therapy decisions and reducing antibiotic prescribing rates in cases where antibiotics may not be warranted. Studies have demonstrated that PCT-guided antibiotic therapy reduces antibiotic exposure, shorter treatment durations, and decreased rates of antibiotic-related adverse events, all contributing to antimicrobial stewardship goals.

Furthermore, IL-6 & IL-10 testing complement PCT by providing additional information on the severity of systemic inflammation and immune dysregulation, which are important considerations in antimicrobial stewardship decision-making. Elevated IL-6 levels have been associated with severe infections & adverse clinical outcomes, while IL-10 levels may reflect immune suppression and increased susceptibility to secondary infections. Biomarker-based diagnostic tests, including IL-6 & IL-10 assays, enable clinicians to risk-stratify patients, monitor disease progression, and tailor antibiotic therapy based on individual patient characteristics & clinical status.

The COVID-19 pandemic has significantly impacted the U.S. market for Procalcitonin, IL-6, and IL-10 tests. The pandemic led to an increase in demand for biomarker tests. These biomarkers became crucial in assessing the severity and prognosis of COVID-19 in patients, thereby driving up the demand for these tests. Healthcare facilities and professionals prioritized COVID-19 management and diagnosis, temporarily shifting focus and resources toward COVID-19-related diagnostics. This resulted in increased production and utilization of tests that could help manage the disease effectively. The urgent need for effective COVID-19 management strategies led to significant government and private sector investment in research and development of diagnostic tests, including those for Procalcitonin, IL-6, and IL-10. This financial support accelerated advancements in test development and availability.

Cost constraints present a significant restraint to the adoption of PCT, IL-6, and IL-10 tests in the U.S. The expenses associated with biomarker testing, including test acquisition, instrumentation, and personnel training, can pose financial challenges for healthcare providers & institutions, particularly in resource-limited settings or underinsured patient populations. Reimbursement policies and coverage limitations may worsen cost concerns, limiting access to biomarker testing as well as hindering its widespread utilization in clinical practice.

U.S. Procalcitonin, IL-6, And IL-10 Tests Market Report Highlights:

  • The inpatient patient type segment held the largest market share in 2023 and is anticipated to witness the fastest CAGR of 4.5% during the forecast period
  • Based on type, the market is segmented into procalcitonin, IL-6, and IL-10. IL-6 segment accounted for largest revenue share of 59.34% in 2023.
  • The hospitals end use segment accounted for the largest revenue share in 2023
  • Based on payer type, the market is segmented into insurance and out-of-pocket. The insurance segment held the largest market share in 2023.
  • The IL-6 application segment accounted for the largest revenue share of in 2023.Sepsis is a major segment in the IL-6 application segment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Patient Type
    • 1.2.2. Type
    • 1.2.3. Application
    • 1.2.4. End use
    • 1.2.5. Payer Type
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of chronic and infectious diseases
      • 3.2.1.2. Antimicrobial stewardship initiatives
      • 3.2.1.3. Clinical utility and evidence-based guidelines
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of testing
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis
    • 3.3.4. Regulatory Scenario

Chapter 4. U.S. Procalcitonin, IL-6, and IL-10 Tests Market: Patient Type Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Procalcitonin, IL-6, and IL-10 Tests Market Movement Analysis
  • 4.3. U.S. Procalcitonin, IL-6, and IL-10 Tests Market Size & Trend Analysis, by Patient Type, 2018 to 2030 (USD Million)
  • 4.4. Inpatient
    • 4.4.1. Inpatient Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.5. Outpatient
    • 4.5.1. Outpatient Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5. U.S. Procalcitonin, IL-6, and IL-10 Tests Market: Type Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Procalcitonin, IL-6, and IL-10 Tests Market Movement Analysis
  • 5.3. U.S. Procalcitonin, IL-6, and IL-10 Tests Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. Procalcitonin
    • 5.4.1. Procalcitonin Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.4.2. Immunoassay
      • 5.4.2.1. Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.4.3. Immunochromatography
      • 5.4.3.1. Immunochromatography Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5. IL-6
    • 5.5.1. IL-6 market estimates and forecast, 2018 - 2030 (USD million)
  • 5.6. IL-10
    • 5.6.1. IL-10 market estimates and forecast, 2018 - 2030 (USD million)

Chapter 6. U.S. Procalcitonin, IL-6, and IL-10 Tests Market: Application Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Procalcitonin, IL-6, and IL-10 Tests Market Movement Analysis
  • 6.3. U.S. Procalcitonin, IL-6, and IL-10 Tests Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Procalcitonin
    • 6.4.1. Procalcitonin Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2. Bacterial Infection
      • 6.4.2.1. Bacterial infection market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Sepsis
      • 6.4.3.1. Sepsis market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. COPD
      • 6.4.4.1. COPD market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Arthritis
      • 6.4.5.1. Arthritis market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Others
      • 6.4.6.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. IL-6
    • 6.5.1. IL-6 market estimates and forecast, 2018 - 2030 (USD million)
    • 6.5.2. Bacterial Infection
      • 6.5.2.1. Bacterial infection market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3. Sepsis
      • 6.5.3.1. Sepsis market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4. Rheumatoid Arthritis
      • 6.5.4.1. Rheumatoid arthritis market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5. Others
      • 6.5.5.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. IL-10
    • 6.6.1. IL-10 Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.6.2. Bacterial Infection
      • 6.6.2.1. Bacterial infection market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. Allergies
      • 6.6.3.1. Allergies market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.4. Inflammatory Disorders
      • 6.6.4.1. Inflammatory disorders market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.5. Others
      • 6.6.5.1. Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. U.S. Procalcitonin, IL-6, and IL-10 Tests Market: End use Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Procalcitonin, IL-6, and IL-10 Tests Market Movement Analysis
  • 7.3. U.S. Procalcitonin, IL-6, and IL-10 Tests Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.4.2. 1-100
      • 7.4.2.1. 1-100 market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.3. 101-250
      • 7.4.3.1. 101-250 market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.4. 251-500
      • 7.4.4.1. 251-500 market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.5. 500 and above
      • 7.4.5.1. 500 and above market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5. Laboratories
    • 7.5.1. Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8. U.S. Procalcitonin, IL-6, and IL-10 Tests Market: Payer Type Business Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Procalcitonin, IL-6, and IL-10 Tests Market Movement Analysis
  • 8.3. U.S. Procalcitonin, IL-6, and IL-10 Tests Market Size & Trend Analysis, by Payer Type, 2018 to 2030 (USD Million)
  • 8.4. Insurance
    • 8.4.1. Insurance Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5. Out Of Pocket
    • 8.5.1. Out of pocket Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9. U.S. Procalcitonin, IL-6, and IL-10 Tests Market: State wise Business Analysis

  • 9.1. U.S. procalcitonin, IL-6, and IL-10 tests market Share By State, 2023 & 2030
  • 9.2. Alabama
    • 9.2.1. Alabama Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.3. Alaska
    • 9.3.1. Alaska Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.4. Arizona
    • 9.4.1. Arizona Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.5. Arkansas
    • 9.5.1. Arkansas Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.6. California
    • 9.6.1. California Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.7. Colorado
    • 9.7.1. Colorado Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.8. Connecticut
    • 9.8.1. Connecticut Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.9. Delaware
    • 9.9.1. Delaware Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.10. Florida
    • 9.10.1. Florida Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.11. Georgia
    • 9.11.1. Georgia Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.12. Hawaii
    • 9.12.1. Hawaii Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.13. Idaho
    • 9.13.1. Idaho Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.14. Illinois
    • 9.14.1. Illinois Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.15. Indiana
    • 9.15.1. Indiana Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.16. Iowa
    • 9.16.1. Iowa Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.17. Kansas
    • 9.17.1. Kansas Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.18. Kentucky
    • 9.18.1. Kentucky Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.19. Louisiana
    • 9.19.1. Louisiana Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.20. Maine
    • 9.20.1. Maine Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.21. Maryland
    • 9.21.1. Maryland Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.22. Massachusetts
    • 9.22.1. Massachusetts Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.23. Michigan
    • 9.23.1. Michigan Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.24. Minnesota
    • 9.24.1. Minnesota Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.25. Mississippi
    • 9.25.1. Mississippi Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.26. Missouri
    • 9.26.1. Missouri Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.27. Montana
    • 9.27.1. Montana Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.28. Nebraska
    • 9.28.1. Nebraska Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.29. Nevada
    • 9.29.1. Nevada Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.30. New Hampshire
    • 9.30.1. New Hampshire Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.31. New Jersey
    • 9.31.1. New Jersey Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.32. New Mexico
    • 9.32.1. New Mexico Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.33. New York
    • 9.33.1. New York Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.34. North Carolina
    • 9.34.1. North Carolina Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.35. North Dakota
    • 9.35.1. North Dakota Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.36. Ohio
    • 9.36.1. Ohio Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.37. Oklahoma
    • 9.37.1. Oklahoma Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.38. Oregon
    • 9.38.1. Oregon Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.39. Pennsylvania
    • 9.39.1. Pennsylvania Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.40. Rhode Island
    • 9.40.1. Rhode Island Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.41. South Carolina
    • 9.41.1. South Carolina Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.42. South Dakota
    • 9.42.1. South Dakota Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.43. Tennessee
    • 9.43.1. Tennessee Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.44. Texas
    • 9.44.1. Texas Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.45. Utah
    • 9.45.1. Utah Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.46. Vermont
    • 9.46.1. Vermont Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.47. Virginia
    • 9.47.1. Virginia Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.48. Washington
    • 9.48.1. Washington Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.49. West Virginia
    • 9.49.1. West Virginia Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.50. Wisconsin
    • 9.50.1. Wisconsin Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)
  • 9.51. Wyoming
    • 9.51.1. Wyoming Procalcitonin, IL-6, and IL-10 Tests Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2023
  • 10.4. Participant's Overview
    • 10.4.1. ARUP Laboratories
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.1.3. Technology Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Promega Corporation
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.2.3. Technology Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Quest Diagnostics Incorporated
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.3.3. Technology Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. BIOMERIEUX
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.4.3. Technology Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. F. Hoffmann-La Roche Ltd.
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.5.3. Technology Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Beckman Coulter, Inc.
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.6.3. Technology Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Thermo Fisher Scientific, Inc.
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.7.3. Technology Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. QuidelOrtho Corporation
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.8.3. Technology Benchmarking
      • 10.4.8.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. procalcitonin, IL-6, and IL-10 tests market, by state, 2018 - 2030 (USD Million)
  • Table 4 U.S. procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 5 U.S. procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 7 U.S. procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 9 Alabama procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 10 Alabama procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 11 Alabama procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 12 Alabama procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Alabama procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 14 Alaska procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 15 Alaska procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 16 Alaska procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 17 Alaska procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Alaska procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 19 Arizona procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 20 Arizona procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 21 Arizona procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 22 Arizona procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Arizona procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 24 Arkansas procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 25 Arkansas procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 26 Arkansas procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 27 Arkansas procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Arkansas procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 29 California procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 30 California procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 31 California procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 32 California procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 33 California procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 34 Colorado procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 35 Colorado procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 36 Colorado procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 37 Colorado procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Colorado procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 39 Connecticut procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 40 Connecticut procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 41 Connecticut procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 42 Connecticut procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Connecticut procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 44 Delaware procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 45 Delaware procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 46 Delaware procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 47 Delaware procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Delaware procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 49 Florida procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 50 Florida procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 51 Florida procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 52 Florida procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Florida procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 54 Georgia procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 55 Georgia procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 56 Georgia procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 57 Georgia procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 58 Georgia procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 59 Hawaii procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 60 Hawaii procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 61 Hawaii procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 62 Hawaii procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Hawaii procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 64 Idaho procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 65 Idaho procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 66 Idaho procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 67 Idaho procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Idaho procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 69 Illinois procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 70 Illinois procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 71 Illinois procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 72 Illinois procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Illinois procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 74 Indiana procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 75 Indiana procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 76 Indiana procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 77 Indiana procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 78 Indiana procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 79 Iowa procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 80 Iowa procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 81 Iowa procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 82 Iowa procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 83 Iowa procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 84 Kansas procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 85 Kansas procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 86 Kansas procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 87 Kansas procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kansas procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 89 Kentucky procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 90 Kentucky procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 91 Kentucky procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 92 Kentucky procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Kentucky procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 94 Louisiana procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 95 Louisiana procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 96 Louisiana procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 97 Louisiana procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 98 Louisiana procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 99 Maine procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 100 Maine procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 101 Maine procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 102 Maine procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 103 Maine procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 104 Maryland procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 105 Maryland procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 106 Maryland procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 107 Maryland procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 108 Maryland procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 109 Massachusetts procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 110 Massachusetts procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 111 Massachusetts procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 112 Massachusetts procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 113 Massachusetts procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 114 Michigan procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 115 Michigan procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 116 Michigan procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 117 Michigan procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 118 Michigan procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 119 Minnesota procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 120 Minnesota procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 121 Minnesota procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 122 Minnesota procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 123 Minnesota procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 124 Mississippi procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 125 Mississippi procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 126 Mississippi procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 127 Mississippi procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 128 Mississippi procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 129 Missouri procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 130 Missouri procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 131 Missouri procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 132 Missouri procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 133 Missouri procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 134 Montana procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 135 Montana procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 136 Montana procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 137 Montana procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 138 Montana procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 139 Nebraska procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 140 Nebraska procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 141 Nebraska procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 142 Nebraska procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 143 Nebraska procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 144 Nevada procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 145 Nevada procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 146 Nevada procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 147 Nevada procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 148 Nevada procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 149 New Hampshire procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 150 New Hampshire procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 151 New Hampshire procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 152 New Hampshire procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 153 New Hampshire procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 154 New Jersey procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 155 New Jersey procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 156 New Jersey procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 157 New Jersey procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 158 New Jersey procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 159 New Mexico procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 160 New Mexico procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 161 New Mexico procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 162 New Mexico procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 163 New Mexico procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 164 New York procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 165 New York procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 166 New York procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 167 New York procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 168 New York procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 169 North Carolina procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 170 North Carolina procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 171 North Carolina procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 172 North Carolina procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 173 North Carolina procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 174 North Dakota procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 175 North Dakota procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 176 North Dakota procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 177 North Dakota procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 178 North Dakota procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 179 Ohio procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 180 Ohio procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 181 Ohio procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 182 Ohio procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 183 Ohio procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 184 Oklahoma procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 185 Oklahoma procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 186 Oklahoma procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 187 Oklahoma procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 188 Oklahoma procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 189 Oregon procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 190 Oregon procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 191 Oregon procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 192 Oregon procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 193 Oregon procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 194 Pennsylvania procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 195 Pennsylvania procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 196 Pennsylvania procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 197 Pennsylvania procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 198 Pennsylvania procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 199 Rhode Island procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 200 Rhode Island procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 201 Rhode Island procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 202 Rhode Island ma procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 203 Rhode Island procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 204 South Carolina procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 205 South Carolina procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 206 South Carolina procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 207 South Carolina procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 208 South Carolina procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 209 South Dakota procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 210 South Dakota procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 211 South Dakota procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 212 South Dakota procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 213 South Dakota procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 214 Tennessee procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 215 Tennessee procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 216 Tennessee procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 217 Tennessee procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 218 Tennessee procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 219 Texas procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 220 Texas procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 221 Texas procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 222 Texas procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 223 Texas procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 224 Utah procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 225 Utah procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 226 Utah procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 227 Utah procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 228 Utah procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 229 Vermont procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 230 Vermont procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 231 Vermont procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 232 Vermont procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 233 Vermont procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 234 Virginia procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 235 Virginia procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 236 Virginia procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 237 Virginia procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 238 Virginia procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 239 Washington procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 240 Washington procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 241 Washington procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 242 Washington procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 243 Washington procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 244 West Virginia procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 245 West Virginia procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 246 West Virginia procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 247 West Virginia procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 248 West Virginia procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 249 Wisconsin procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 250 Wisconsin procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 251 Wisconsin procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 252 Wisconsin procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 253 Wisconsin procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)
  • Table 254 Wyoming procalcitonin, IL-6, and IL-10 tests market, by patient type, 2018 - 2030 (USD Million)
  • Table 255 Wyoming procalcitonin, IL-6, and IL-10 tests market, by type, 2018 - 2030 (USD Million)
  • Table 256 Wyoming procalcitonin, IL-6, and IL-10 tests market, by application, 2018 - 2030 (USD Million)
  • Table 257 Wyoming procalcitonin, IL-6, and IL-10 tests market, by end use, 2018 - 2030 (USD Million)
  • Table 258 Wyoming procalcitonin, IL-6, and IL-10 tests market, by payer type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 U.S. procalcitonin, IL-6, and IL-10 tests market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market outlook
  • Fig. 13 Related/ancillary market outlook
  • Fig. 14 Industry value chain analysis
  • Fig. 15 U.S. procalcitonin, IL-6, and IL-10 tests market driver analysis
  • Fig. 16 U.S. procalcitonin, IL-6, and IL-10 tests market restraint analysis
  • Fig. 17 U.S. procalcitonin, IL-6, and IL-10 tests market: Porter's analysis
  • Fig. 18 U.S. procalcitonin, IL-6, and IL-10 tests market: Patient type outlook and key takeaways
  • Fig. 19 U.S. procalcitonin, IL-6, and IL-10 tests market: Patient type market share analysis, 2023 - 2030
  • Fig. 20 U.S. procalcitonin, IL-6, and IL-10 tests by inpatient market, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. procalcitonin, IL-6, and IL-10 tests by outpatient market, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. procalcitonin, IL-6, and IL-10 tests market: Type outlook and key takeaways
  • Fig. 23 U.S. procalcitonin, IL-6, and IL-10 tests market: Type market share analysis, 2023 - 2030
  • Fig. 24 U.S. procalcitonin, IL-6, and IL-10 tests by procalcitonin market, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. procalcitonin, IL-6, and IL-10 tests by immunoassay market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. procalcitonin, IL-6, and IL-10 tests by immunochromatography market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. procalcitonin, IL-6, and IL-10 tests by others market, 2018 - 2030 (USD Million)
  • Fig. 28 U.S. procalcitonin, IL-6, and IL-10 tests by IL-6 market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. procalcitonin, IL-6, and IL-10 tests by IL-10 market, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. procalcitonin, IL-6, and IL-10 tests market: Application outlook and key takeaways
  • Fig. 31 U.S. procalcitonin, IL-6, and IL-10 tests market: Application market share analysis, 2023 - 2030
  • Fig. 32 U.S. procalcitonin, IL-6, and IL-10 tests by procalcitonin market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. procalcitonin, IL-6, and IL-10 tests by bacterial infection market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. procalcitonin, IL-6, and IL-10 tests by sepsis market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. procalcitonin, IL-6, and IL-10 tests by COPD market, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. procalcitonin, IL-6, and IL-10 tests by arthritis market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. procalcitonin, IL-6, and IL-10 tests by others market, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. procalcitonin, IL-6, and IL-10 tests by IL-6 market, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. procalcitonin, IL-6, and IL-10 tests by bacterial infection market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. procalcitonin, IL-6, and IL-10 tests by sepsis market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. procalcitonin, IL-6, and IL-10 tests by rheumatoid arthritis market, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. procalcitonin, IL-6, and IL-10 tests by others market, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. procalcitonin, IL-6, and IL-10 tests by IL-10 market, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. procalcitonin, IL-6, and IL-10 tests by bacterial infection market, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. procalcitonin, IL-6, and IL-10 tests by allergies market, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. procalcitonin, IL-6, and IL-10 tests by inflammatory disorders market, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. procalcitonin, IL-6, and IL-10 tests by others market, 2018 - 2030 (USD Million)
  • Fig. 48 U.S. procalcitonin, IL-6, and IL-10 tests market: End use outlook and key takeaways
  • Fig. 49 U.S. procalcitonin, IL-6, and IL-10 tests market: End use market share analysis, 2023 - 2030
  • Fig. 50 U.S. procalcitonin, IL-6, and IL-10 tests by hospitals market, 2018 - 2030 (USD Million)
  • Fig. 51 U.S. procalcitonin, IL-6, and IL-10 tests by 1-100 market, 2018 - 2030 (USD Million)
  • Fig. 52 U.S. procalcitonin, IL-6, and IL-10 tests by 101-250 market, 2018 - 2030 (USD Million)
  • Fig. 53 U.S. procalcitonin, IL-6, and IL-10 tests by 251-500 market, 2018 - 2030 (USD Million)
  • Fig. 54 U.S. procalcitonin, IL-6, and IL-10 tests by 500 and above market, 2018 - 2030 (USD Million)
  • Fig. 55 U.S. procalcitonin, IL-6, and IL-10 tests by laboratories market, 2018 - 2030 (USD Million)
  • Fig. 56 U.S. procalcitonin, IL-6, and IL-10 tests by others market, 2018 - 2030 (USD Million)
  • Fig. 57 U.S. procalcitonin, IL-6, and IL-10 tests market: Payer type outlook and key takeaways
  • Fig. 58 U.S. procalcitonin, IL-6, and IL-10 tests market: Payer type market share analysis, 2023 - 2030
  • Fig. 59 U.S. procalcitonin, IL-6, and IL-10 tests by insurance market, 2018 - 2030 (USD Million)
  • Fig. 60 U.S. procalcitonin, IL-6, and IL-10 tests by out of pocket market, 2018 - 2030 (USD Million)
  • Fig. 61 Alabama procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Alaska procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Arizona procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Arkansas procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 California procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Colorado procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Connecticut procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Delaware procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Florida procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Georgia procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Hawaii procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Idaho procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Illinois procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Indiana procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Iowa procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Kansas procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Kentucky procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Louisiana procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Maine procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Maryland procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Massachusetts procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Michigan procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Minnesota procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Mississippi procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Missouri procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Montana procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Nebraska procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Nevada procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 New Hampshire procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 New Jersey procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 New Mexico procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 New York procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 North Carolina procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 North Dakota procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Ohio procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Oklahoma procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Oregon procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Pennsylvania procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Rhode Island procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 South Carolina procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 101 South Dakota procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Tennessee procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 103 Texas procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 Utah procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 Vermont procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 106 Virginia procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 Washington procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 108 West Virginia procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 109 Wisconsin procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 110 Wyoming procalcitonin, IL-6, and IL-10 tests market estimates and forecast, 2018 - 2030 (USD Million)